MAPT and Alzheimer disease: Exosomes biogenesis inhibition via the blocking of neutral sphingomyelinase 2 (nSmase2) activity, a critical enzyme regulating ceramide biogenesis, significantly decreased Aβ plaques as well as tau propagation in an AD mice model [73].